Tag: TechCrunch

Browse our exclusive articles!

AI Doomerism is Exaggerated and Other Tech News

AI doomsday is overblown, says tech journalist Devin Coldewey. Fear-mongering is unwarranted, and there's no imminent threat to humanity from AI.

Latest Developments in Generative AI

Stay up-to-date with the ever-evolving field of generative AI. TechCrunch+ has got you covered with insightful articles on the latest breakthroughs and how companies can leverage these new technologies for success. Join us on this exciting AI journey!

How to Use ChatGPT on Your iPhone

Discover the convenience of OpenAI's official ChatGPT app, now available on iPhone and other mobile devices. Experience the smooth and fast conversational interface, full access to GPT-4 model, speech-to-text conversing option and available for download in the US App Store. Plus, creating a shortcut with the OpenAI API is also available! Get ready for a revolutionary AI experience!

Musk’s Donation to OpenAI: $15 Million Traced

Elon Musk, the outgoing Twitter CEO, reportedly pledges to donate $100 million to the ChatGPT team at OpenAI but recent reports only trace back $15 million. Get details on the investigation, Musk's confirmed $10 million donation, and the rift between Musk and the OpenAI founders.

Revolutionising TechCrunch Disrupt: An Exciting Three-Day Event Across 8 Stages Across One City

Discover TechCrunch Disrupt 2023, the ultimate startup platform where founders, investors, and experts come together to discuss the most groundbreaking developments, learn essential tools and make essential connections. Experience six industry tracks, the Builders stage, TC Sessions and more. Join the competition and win a $100,000 prize. Get access to resources for entrepreneurs, founders and investors. Be a part of the future!

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img